- 1Department of Neurology, The Second People’s Hospital of Neijiang, Neijiang, Sichuan, China
- 2General Practice Ward/International Medical Center Ward, Teaching and Research Section of General Practice, General Practice Medical Center, West China Hospital, General Practice Research Institute, Sichuan University, Chengdu, China
- 3Department of Emergency Medicine, Institute of Disaster Medicine and Institute of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, China
- 4Nursing Key Laboratory of Sichuan Province, Department of Periodical Press, National Clinical Research Center for Geriatrics, Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China
Aims: Stroke is a leading cause of disability and death worldwide, with family support playing a pivotal role in the recovery process. This study aimed to evaluate the association between family support levels and the short-term functional prognosis of patients with acute ischemic stroke.
Materials and methods: A total of 124 patients admitted to the Department of Neurology at Second People’s Hospital of Neijiang were included, with an average age of 68 years. Family support was assessed by the Family Support Questionnaire (FSQ) and the Family APGAR Questionnaire. The primary outcome was functional independence, defined as a Modified Rankin Scale (mRS) score of 0–2, assessed 6 months after discharge. Secondary outcomes included lifestyle behaviors and medication adherence. Multivariate logistic and linear regression were used to analyze the association between family support and functional independence.
Results: Compared to patients with FSQ of 0–5, FSQ of 10–15 were significantly associated with greater functional independence (OR: 1.666, 95% CI 1.236–2.214, P = 0.005) and mRS changes between baseline and follow-up at 6-months (β = −1.001, 95% CI −1.418 to −0.584, P < 0.001). However, the APGAR score was not significantly associated with functional recovery (P > 0.05). Lifestyle improvements were noted post-stroke, but no significant differences were observed among different family support levels (P > 0.05). Higher FSQ scores and APGAR scores were associated with better medication adherence (P < 0.001).
Conclusion: The study concludes family support is positively associated with functional recovery and medication adherence, further studies are needed to clarify whether improved medication adherence mediates this association.
Introduction
Stroke remains a global public health challenge, causing a substantial burden on socioeconomic development and human health (1–4). As the second leading cause of death worldwide, stroke-related mortality has exhibited significant growth over the past three decades (1, 2). Notably, ischemic stroke dominates among stroke subtypes, with both its incidence and disability rates demonstrating persistent upward trends (5). While thrombolysis and thrombectomy therapies have proven effective for acute ischemic stroke, limitations in treatment time windows and healthcare accessibility result in fewer than 1% of patients receiving timely intervention, with over half of survivors developing severe functional impairments (6–10). Against the backdrop of population aging-marked by multi-organ functional decline and comorbidities in elderly patients-post-stroke recovery becomes increasingly challenging (11), adding to the socioeconomic burden that needs to be addressed.
Families, as foundational societal units, play an irreplaceable role in stroke rehabilitation (12). Family support encompasses material assistance, emotional care, financial aid, and social resource coordination (13). By addressing daily living needs, enhancing treatment adherence, and facilitating rehabilitation exercises, such support positively impacts post-stroke recovery and stroke recurrence prevention (14, 15). However, the benefits of family support for the recovery of stroke patients are still in dispute. Some studies found that family support may be related to the psychological recovery of stroke patients, but not to their physical wellbeing (16, 17). This may be related to patients having received good rehabilitation treatment during their hospital stay. In fact, patients’ income and economic level are independent factors affecting the recovery of stroke patients, which may influence access to medical resources (18, 19). In resource-poor areas, family support is particularly important in the rehabilitation of stroke patients (20). Nevertheless, chronic diseases may diminish the family support available to patients, thereby compromising their recovery (21). Therefore, whether family support for stroke patients in resource-poor areas has a positive effect on their recovery is still unknown.
Since post-stroke dysfunction is the leading cause of disability in China (22, 23), rehabilitation interventions are necessary. Functional recovery refers to the degree of recovery of body structure and function to the pre-stroke state, which mainly occurs in the first 6 months after stroke, especially in the first 3 months (24–26). However, in China, due to the imperfection of primary healthcare institutions and high hospitalization costs, the rehabilitation of stroke patients primarily takes place at home (27, 28). Therefore, it is necessary to evaluate the short-term functional recovery of patients with acute ischemic stroke with different family support levels, and understand the prognosis of short-term functional recovery of patients with acute ischemic stroke with different family support levels. This study aims to clarify how distinct family support level influence short-term functional prognoses in acute ischemic stroke patients, thereby providing a theoretical basis for home-based rehabilitation strategies.
Population and study design
Our study initially screened 280 patients with ischemic stroke admitted to the Department of Neurology at the Second People’s Hospital of Neijiang from May 1, 2019, to September 30, 2019. According to the guidelines (29), acute ischemic stroke was defined as: (1) acute onset; (2) presence of focal neurological deficits (e.g., unilateral facial or limb weakness or numbness, aphasia, etc.); (3) identification of a responsible lesion on CT/MRI or persistence of symptoms/signs for >24 h; (4) exclusion of non-vascular etiologies; and (5) exclusion of intracerebral hemorrhage on imaging. Among all patients, we excluded patients (1) with severe organ failure (n = 13), aphasia [Boston Diagnostic Aphasia Battery grade 0–2 (30), n = 25], psychiatric disorders (n = 34), or malignancies (n = 6); (2) lacked full cognitive capacity or refused to sign the informed consent form (n = 73); (3) who were lost to follow-up (n = 5). Finally, 124 patients with acute ischemic stroke were included in the study (Figure 1). This study was supported by the China National Stroke Screening Survey (CNSSS). It was approved by the Medical Ethics Committee of the Second People’s Hospital of Neijiang, with approval number 2018073. All participants and their proxies provided written informed consent.
Prior to the implementation of the study, all data collectors underwent standardized training, which included structured questionnaire interviews, standardized blood pressure measurement, and standardized laboratory testing procedures. Only those who passed the assessment were permitted to participate in the study. An independent quality control group was established during the study to dynamically monitor the entire data collection process, including questionnaire completion, physical examination, and laboratory testing. Participants were admitted within 72 h of symptom onset and all baseline data were collected within 48 h of hospital admission. Data management was conducted using a dual-independent data entry system. After data entry, consistency checks were performed. Any discrepancies in the data entries were corrected after dual verification with the original paper records.
Family support assessment
Family support was assessed using the Family Support Questionnaire (FSQ) and the Family Adaptation, Partnership, Growth, Affection and Resolve (APGAR) Questionnaire. The FSQ is an appropriate instrument for assessing family support in the Chinese population and has been validated in previous study (Cronbach’s α = 0.85) (31), with reference to the Family Support Scale (Perceived Social Support from Family Scale, PSS-Fa) designed by Procidano and Heller in the United States in 1983 (32–34). The FSQ captures tangible supportive behaviors (emotion, finance, daily affairs, or health) directly relevant to post-stroke recovery (35). The total score ranges from 0 to 15 points, based on the scores, family behavioral support is categorized into three levels: low level (0–5 points), medium level (6–10 points), and high level (11–15 points).
The Family APGAR Questionnaire was developed by American scholar Smilkstein in 1978 (36). The APGAR Questionnaire has been validated and shown to be appropriate for use in the Chinese population, a survey conducted among 2,635 Chinese individuals demonstrated that the APGAR Questionnaire has good internal consistency in the Chinese population (Cronbach’s α = 0.94) (37). The Family APGAR Questionnaire captures the close relationships between the respondents and other family members, it is widely used in stroke recovery (38, 39). The total score ranges from 0 to 10 points. Based on the scores, family function is categorized into three levels: severe dysfunction (0–3 points), moderate dysfunction (4–6 points), and good function (7–10 points), which correspond to low, medium, and high levels of family care and support, respectively.
Outcome assessment
The primary outcome was assessed using the internationally recommended scale for functional evaluation of acute ischemic stroke (Chinese version), namely the Modified Rankin Scale (mRS) (40–42). Previously, several studies in China used mRS to assess the functional status of stroke patients (42–44). The mRS score ranges from 0 to 6, divided into seven levels. Based on previous studies, we defined scores of 0–2 as functional independence and scores of 3–6 as functional dependence (45, 46). We evaluated the mRS scores of participants both at admission and 6 months after discharge. Additionally, we calculated the difference between the mRS score at 6 months after discharge and the admission score, denoted as ΔmRS.
Secondary outcomes included changes in lifestyle behaviors (alcohol consumption, smoking, exercise, and healthy diet score) and medication adherence at follow-up, which are key modifiable risk factors in clinical guidelines. Alcohol consumption, smoking status and physical activity were assessed with standardized instruments that have been validated (47–50). The healthy diet score (51) was assessed by seven components, details of which can be referred to in previous studies. Medication adherence was evaluated using the Brief Medication Questionnaire (BMQ) (52), which includes necessity beliefs and concern beliefs. The difference between these two beliefs constitutes the final score. The BMQ has been validated in the Chinese population and has demonstrated good validity and reliability (Cronbach’s α = 0.759) (53).
Covariates assessment
The following covariates were assessed: age (years), sex (male/female), educational status (years of schooling: <6, 6–9, >9), alcohol status (current, former/never), smoking status (current, former/never), physical activity (whether meeting the guideline recommendations) (54), hypertension (yes/no), diabetes (yes/no), hyperlipidemia (yes/no), and National Institutes of Health Stroke Scale (NIHSS) score. The above information was obtained from patient self-reports or electronic medical records during hospitalization.
Statistical analysis
Continuous data are presented as mean and standard deviation. Categorical data are described using frequencies and percentages. For functional recovery, univariate and multivariate logistic regression analyses were built. With low family support participants as the reference group, the multivariate logistic regression analysis was adjusted for all the covariates mentioned above and baseline mRS scores. Additionally, changes in mRS scores were assessed using univariate and multivariate linear regression, with the same adjustments as in the multivariate logistic regression. For secondary outcomes, ANOVA analysis and chi-square tests were used according to the data types. Statistical significance was defined as a p-value < 0.05 for two-tailed tests. All analyses were performed using SPSS version 27.0 (IBM Corp., Armonk, NY, USA).
Results
Baseline characteristics
A total of 124 participants were included in this study (age: 68.44 ± 11.27 years, male: 71 [57.26%]) with follow-up of 6 months. At baseline, there were no significant differences among participants with different levels of FSQ and APGAR score in terms of age, gender ratio, smoking and alcohol history, hypertension, hyperglycemia, hyperlipidemia, and mRS scores (Table 1).
Association between FSQ scores and mRS scores
In the unadjusted model (Figure 2), compared with low-support patients, those with high support exhibited a 52% relative increase in the odds of functional independence (OR = 1.666, 95% CI 1.236–2.214, P = 0.010). Additionally, each one-point increase in the FSQ score was associated with a 6.8% increase in the odds of functional independence (OR = 1.068, 95% CI 1.008–1.116, P < 0.001). In the fully adjusted logistic regression (Figure 2), participants with high FSQ score level had an odds ratio (OR) of 1.517 (95% CI 1.224–1.895, P = 0.005), and each one-point increase was associated with an OR of 1.061 (95% CI 1.004–1.129, P < 0.001).
Figure 2. Association between family support level and functional independence. (A) Unadjusted model; (B) fully-adjusted models. Fully-adjusted models were adjusted for age, sex, educational status, alcohol status, smoking status, physical activity, hypertension, diabetes, hyperlipidemia, and NIHSS score.
In the fully adjusted linear regression (Table 2), in the high FSQ score group, mRS scores decreased (β = −1.001, 95% CI −1.418 to −0.584, P < 0.001) compared to low FSQ score group and each one-point increase in FSQ score was associated with a mean decrease in mRS scores of 0.127 (β = −0.127, 95% CI −0.179 to −0.075, P < 0.001). Thus, higher FSQ score was linked to greater functional independence in post-stroke patients.
Association between APGAR scores and mRS scores
In the unadjusted model (Figure 2), compared to low score groups, high APGAR score group were associated with greater functional independence (OR = 1.475, 95% CI 1.137–1.875, P = 0.027). For each one-point increase in APGAR scores, the odds of functional independence increased by 5.6% (OR = 1.056, 95% CI 1.008–1.132, P = 0.006). However, in the fully adjusted logistic regression (Figure 2), APGAR score level was not significantly associated with functional independence (P > 0.05).
In the fully adjusted linear regression (Table 2), there was no association between APGAR score group and mRS scores decreased. While each one-point increase in APGAR score was associated with a mean decrease in mRS scores of 0.073 (β = −0.073, 95% CI −0.138 to −0.007, P = 0.030). Although APGAR categorical variable was no longer significantly associated with functional independence after multivariable adjustment, each unit increase in its continuous score remained associated with measurable improvement in mRS.
Association between lifestyle behaviors and medication adherence
Compared to the baseline, the overall proportion of current smokers (27.42% vs. 12.10%) and drinkers (20.97% vs. 5.65%) among participants was reduced after 6 months, while the healthy diet score (2.44 ± 1.18 vs. 3.91 ± 0.71) and proportion of exercising (6.45% vs. 20.97%) increased. However, there were no significant differences in smoking, drinking, exercise, and healthy diet scores among the groups with different levels of FSQ and APGAR scores (Table 3). In terms of medication adherence (Table 3), a higher level of FSQ score (low vs. medium vs. High: 3.24 ± 1.48 vs. 3.73 ± 1.03 vs. 5.40 ± 1.01, P < 0.001) and APGAR score (low vs. medium vs. high: 4.30 ± 1.16 vs. 4.33 ± 1.51 vs. 4.76 ± 1.47, P = 0.039) were associated with higher medication adherence. Collectively, higher levels of FSQ and APGAR scores were statistically associated with better medication adherence but not with short-term lifestyle change.
Discussion
In this study, 124 patients with acute ischemic stroke were included, with an average age of 68 years, mainly distributed in the age group of 60–69 years, which is consistent with the age characteristics of the stroke registry data in China (55). High level of family support (FSQ 11–15 points) showed 1.52-fold higher odds of functional independence and each one-point increase in the FSQ was associated with a 0.127-point decrease in the mRS score, extending previous reports that robust family support improves functional recovery after stroke by quantifying the dose–response relationship. In contrast, APGAR score levels were no longer associated with functional independence after multivariable adjustment. Regardless of whether assessed by FSQ or APGAR score, higher family support was associated with better medication adherence. It should be noted that, although we found that the overall lifestyle improved after stroke compared with before, no significant differences were found between different levels of family support. In summary, this study further highlights the importance of family support for post-stroke functional recovery.
Family support refers to the psychological, social, and behavioral support provided by family members to patients. It has a positive impact on patients’ prognosis, including depression, anxiety, relationship satisfaction, disability, and mortality after illness (56, 57). The Family Support Questionnaire (FSQ) score is mainly used to assess the degree of family support perceived by individuals, quantifying the level of support provided by family members in terms of emotion, finance, daily affairs, or health (35). High levels of family support may be associated with improved patient prognosis. For example, a study in Iran targeting the elderly in rural communities showed that high level of family support were significantly associated with increased activities of daily living among the elderly (58). Additionally, a cross-sectional study demonstrated a positive correlation between high levels of family support and self-efficacy in stroke patients (29). However, an Indonesian tuberculosis cohort found no association between family support and anti-tuberculosis medication adherence (59).
The APGAR score primarily focuses on family function (60). Previous studies showed that lower APGAR score may be an important factor in the occurrence of post-stroke fatigue and lower health beliefs among stroke patients (61, 62). Additionally, the APGAR score was not significantly correlated with patient gender, age, marital status, education level, or socioeconomic status (63). In this study, after fully adjusting the model, the APGAR score was not associated with functional recovery of patients with acute ischemic stroke, which may suggest that family support assessed by FSQ score may play a more important role in the functional recovery of stroke patients and further studies are needed to explore the underlying reasons.
Due to the long recovery time for stroke patients, high hospitalization costs and lack of medical resources, most stroke patients in China only conduct rehabilitation exercise at home after discharge (28, 64, 65). Therefore, functional recovery supported by the family is particularly important for stroke patients in China. Our study clarified the positive impact of family support level on the recovery of patients with acute ischemic stroke, offering a new perspective for improving stroke functional recovery in areas with limited medical resources. This may be related to better family support increasing patients’ health beliefs, self-efficacy, emotional improvement, and medication adherence. Although our study found that lifestyle behaviors were similar in different levels of FSQ and APGAR scores at both baseline and the 6-months follow-up, this may be due to the short follow-up period, which led to insufficient observation.
The study has several limitations. First, the observational, non-randomized design precludes causal inference; all reported associations should be interpreted as correlational. Second, neither patients nor outcome assessors were blinded to the support-level grouping, introducing potential assessor bias in the 6-months mRS evaluation and response bias in self-reported questionnaires. Third, the evaluation of family support and medication adherence relied entirely on patient self-report, which is susceptible to recall and social-desirability bias. Fourth, the single-center design and relatively small sample (n = 124) limit external validity and the ability to detect small effect sizes, especially in the lifestyle subgroup analyses. Fifth, the 6-months follow-up, while sufficient for functional outcomes, may be too short to observe the full trajectory of medication adherence or lifestyle change, and longer-term assessments are warranted. Finally, the study did not record the exact relationship between the patient and the family member providing support; thus, we could not examine whether relationship type influences the level of family support. Future studies need to be large-scale and have longer follow-up periods to clarify the impact of family support level on the prognosis of stroke patients.
Conclusion
The level of family support is positively correlated with functional recovery, and improvement of medication adherence may be a potential mechanism. Our study suggests that family support needs to be assessed among stroke patients after discharge. Enhancing family support may be an essential pathway to improve functional recovery of stroke patients in limited medical resources areas. Future research should investigate the association between family support levels and lifestyle improvements with larger samples and longer follow-up periods.
Data availability statement
The original contributions presented in this study are included in this article/supplementary material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by the Medical Ethics Committee of the Second People’s Hospital of Neijiang, with approval number 2018073. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation in this study was provided by the participants’ legal guardians/next of kin.
Author contributions
MZ: Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing. YZ: Data curation, Methodology, Software, Writing – original draft, Writing – review & editing. YJ: Data curation, Investigation, Methodology, Software, Writing – review & editing. YY: Investigation, Methodology, Validation, Writing – review & editing. YC: Data curation, Investigation, Methodology, Writing – review & editing. DL: Data curation, Investigation, Writing – review & editing. YgZ: Formal analysis, Software, Validation, Writing – review & editing. YL: Data curation, Investigation, Methodology, Writing – review & editing. QZ: Resources, Software, Writing – review & editing. JH: Conceptualization, Investigation, Supervision, Writing – review & editing. XL: Conceptualization, Project administration, Supervision, Visualization, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research and/or publication of this article. This work was supported financially by grants from 2022 Neijiang City Key Science and Technology Project Plan (Social Development Category, No. 34), Noncommunicable Chronic Diseases-National Science and Technology Major Project (Nos. 2023ZD0506101 and 2023ZD0506100), Sichuan Science and Technology Program (Nos. 2024NSFSC0661, 2024NSFSC1534, and 24ZDYF0065), Sichuan Provincial Health Commission (Nos. 2023-103 and 2024-102), 135 Project for Disciplines of Excellence-Clinical Research Incubation Project and Artificial Intelligence (Nos. 2023HXFH002 and 0040206107081), and Postdoctor Research Fund of West China Hospital, Sichuan University (No. 2024HXBH067), CDHT Health Bureau (Nos. 2024004 and 2024005).
Acknowledgments
We appreciate the participants for their participation and contribution to this research.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Murray CJL. The global burden of disease study at 30 years. Nat Med. (2022) 28:2019–26. doi: 10.1038/s41591-022-01990-1
3. Hou S, Zhang Y, Xia Y, Liu Y, Deng X, Wang W, et al. Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021. Eur J Neurol. (2024) 31:e16481. doi: 10.1111/ene.16481
4. Donkor ES. Stroke in the 21(st) Century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. (2018) 2018:3238165. doi: 10.1155/2018/3238165
5. Mendis S. Stroke disability and rehabilitation of stroke: World Health Organization perspective. Int J Stroke. (2013) 8:3–4.
6. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. (2019) 50:e344–418. doi: 10.1161/str.0000000000000211
7. Pierot L, Jarayaman M, Szikora I, Hirsch J, Baxter B, Miyachi S, et al. Standards of practice in acute ischemic stroke intervention international recommendations. Can J Neurol Sci. (2019) 46:269–74. doi: 10.1017/cjn.2019.1
8. Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. (2018) 378:11–21. doi: 10.1056/NEJMoa1706442
9. Leng T, Xiong ZG. Treatment for ischemic stroke: From thrombolysis to thrombectomy and remaining challenges. Brain Circ. (2019) 5:8–11. doi: 10.4103/bc.bc_36_18
10. The National Institute of Neurological Disorders and Stroke (Ninds) rt-Pa Stroke Study Group. A systems approach to immediate evaluation and management of hyperacute stroke: Experience at eight centers and implications for community practice and patient care. Stroke. (1997) 28:1530–40. doi: 10.1161/01.str.28.8.1530
11. Knoflach M, Matosevic B, Rücker M, Furtner M, Mair A, Wille G, et al. Functional recovery after ischemic stroke–a matter of age: data from the Austrian Stroke Unit Registry. Neurology. (2012) 78:279–85. doi: 10.1212/WNL.0b013e31824367ab
12. Levasseur MA, Ferrari M, McIlwaine S, Iyer SN. Peer-driven family support services in the context of first-episode psychosis: Participant perceptions from a Canadian early intervention programme. Early Interv Psychiatry. (2019) 13:335–41. doi: 10.1111/eip.12771
13. Seshadri K, Sivakumar T, Jagannathan A. The Family Support Movement and Schizophrenia in India. Curr Psychiatry Rep. (2019) 21:95. doi: 10.1007/s11920-019-1081-5
14. Smith LN, Lawrence M, Kerr SM, Langhorne P, Lees KR. Informal carers’ experience of caring for stroke survivors. J Adv Nurs. (2004) 46:235–44. doi: 10.1111/j.1365-2648.2004.02983.x
15. Barskova T, Wilz G. Interdependence of stroke survivors’ recovery and their relatives’ attitudes and health: a contribution to investigating the causal effects. Disabil Rehabil. (2007) 29:1481–91. doi: 10.1080/09638280601029399
16. Dennis M, O’Rourke S, Slattery J, Staniforth T, Warlow C. Evaluation of a stroke family care worker: results of a randomised controlled trial. Bmj. (1997) 314:1071–6; discussion 1076–7. doi: 10.1136/bmj.314.7087.1071
17. Mant J, Winner S, Roche J, Wade DT. Family support for stroke: one year follow up of a randomised controlled trial. J Neurol Neurosurg Psychiatry. (2005) 76:1006–8. doi: 10.1136/jnnp.2004.048991
18. Seifi A, Elliott RJ, Elsehety MA. Impact of Patients’ income on stroke prognosis. J Stroke Cerebrovasc Dis. (2016) 25:2308–11. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.024
19. Khan F, Turner-Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Postgrad Med J. (2008) 84:385. doi: 10.1136/jnnp.2007.127563
20. Determeijer JJ, van Waard JD, Leopold SJ, Spijker R, Agyemang C, Vugt MV. The barriers and facilitators family caregivers experience when participating in resource-limited hospital care: a qualitative systematic review. BMJ Glob Health. (2024) 9:e015956. doi: 10.1136/bmjgh-2024-015956
21. Holmes AM, Deb P. The effect of chronic illness on the psychological health of family members. J Ment Health Policy Econ. (2003) 6:13–22.
22. Ma Q, Li R, Wang L, Yin P, Wang Y, Yan C, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. (2021) 6:e897–906. doi: 10.1016/s2468-2667(21)00228-0
23. Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. (2019) 18:394–405. doi: 10.1016/s1474-4422(18)30500-3
24. Bernhardt J, Hayward KS, Kwakkel G, Ward NS, Wolf SL, Borschmann K, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: the Stroke Recovery and Rehabilitation Roundtable taskforce. Int J Stroke. (2017) 12:444–50. doi: 10.1177/1747493017711816
25. Rosbergen IC, Grimley RS, Hayward KS, Walker KC, Rowley D, Campbell AM, et al. Embedding an enriched environment in an acute stroke unit increases activity in people with stroke: a controlled before-after pilot study. Clin Rehabil. (2017) 31:1516–28. doi: 10.1177/0269215517705181
26. Prabhakaran S, Zarahn E, Riley C, Speizer A, Chong JY, Lazar RM, et al. Inter-individual variability in the capacity for motor recovery after ischemic stroke. Neurorehabil Neural Repair. (2008) 22:64–71. doi: 10.1177/1545968307305302
27. Stinear CM, Smith MC, Byblow WD. Prediction tools for stroke rehabilitation. Stroke. (2019) 50:3314–22. doi: 10.1161/strokeaha.119.025696
28. Wagachchige Muthucumarana M, Samarasinghe K, Elgán C. Caring for stroke survivors: experiences of family caregivers in Sri Lanka - a qualitative study. Top Stroke Rehabil. (2018) 25:397–402. doi: 10.1080/10749357.2018.1481353
29. Liu L, Chen W, Zhou H, Duan W, Li S, Huo X, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol. (2020) 5:159–76. doi: 10.1136/svn-2020-000378
30. Draper I. The assessment of aphasia and related disorders. J Neurol Neurosurg Psychiatry. (1973) 36:894.
31. Zhang HY. Correlation between family support and self-care behaviors in breast cancer patients. J Nurs Sci. (1999) 14:195–6.
32. Li G, Hu H, Dong Z, Arao T. Development of the Chinese family support scale in a sample of Chinese patients with hypertension. PLoS One. (2013) 8:e85682. doi: 10.1371/journal.pone.0085682
33. Procidano ME, Heller K. Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol. (1983) 11:1–24. doi: 10.1007/bf00898416
34. Yang X, Xue M, Pauen S, He H. Psychometric properties of the chinese version of multidimensional scale of perceived social support. Psychol Res Behav Manag. (2024) 17:2233–41. doi: 10.2147/prbm.S463245
35. Toledano-Toledano F, Luna D. The psychosocial profile of family caregivers of children with chronic diseases: a cross-sectional study. Biopsychosoc Med. (2020) 14:29. doi: 10.1186/s13030-020-00201-y
36. Smilkstein G. The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract. (1978) 6:1231–9.
37. Nan H, Ni MY, Lee PH, Tam WW, Lam TH, Leung GM, et al. Psychometric evaluation of the Chinese version of the Subjective Happiness Scale: evidence from the Hong Kong FAMILY Cohort. Int J Behav Med. (2014) 21:646–52. doi: 10.1007/s12529-014-9389-3
38. de Oliveira SC, dos Santos AA, Pavarini SC. [The relationship between depressive symptoms and family functioning in institutionalized elderly]. Rev Esc Enferm USP. (2014) 48:66–72. doi: 10.1590/s0080-623420140000100008
39. Zhang W, Gao YJ, Ye MM, Zhou LS. Post-stroke family resilience is correlated with family functioning among stroke survivors: The mediating role of patient’s coping and self-efficacy. Nurs Open. (2024) 11:e2230. doi: 10.1002/nop2.2230
40. Broderick JP, Adeoye O, Elm J. Evolution of the modified rankin scale and its use in future stroke trials. Stroke. (2017) 48:2007–12. doi: 10.1161/strokeaha.117.017866
41. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. (1988) 19:604–7. doi: 10.1161/01.str.19.5.604
42. Yuan JL, Bruno A, Li T, Li SJ, Zhang XD, Li HY, et al. Replication and extension of the simplified modified rankin scale in 150 Chinese stroke patients. Eur Neurol. (2012) 67:206–10. doi: 10.1159/000334849
43. Tao C, Liu T, Cui T, Liu J, Li Z, Ren Y, et al. Early tirofiban infusion after intravenous thrombolysis for stroke. N Engl J Med. (2025) 393:1191–201. doi: 10.1056/NEJMoa2503678
44. Yuan J, Wang Y, Hu W, Bruno A. The reliability and validity of a novel Chinese version simplified modified Rankin scale questionnaire (2011). BMC Neurol. (2020) 20:127. doi: 10.1186/s12883-020-01708-1
45. Krieger P, Melmed KR, Torres J, Zhao A, Croll L, Irvine H, et al. Pre-admission antithrombotic use is associated with 3-month mRS score after thrombectomy for acute ischemic stroke. J Thromb Thrombolysis. (2022) 54:350–9. doi: 10.1007/s11239-022-02680-y
46. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for Stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. (2018) 378:708–18. doi: 10.1056/NEJMoa1713973
47. Wang YJ, Li ZX, Gu HQ, Zhai Y, Zhou Q, Jiang Y, et al. China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations. Stroke Vasc Neurol. (2022) 7:415–50. doi: 10.1136/svn-2021-001374
48. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. (2003) 35:1381–95. doi: 10.1249/01.Mss.0000078924.61453.Fb
49. Yang GH, Li Q, Wang CX, Hsia J, Yang Y, Xiao L, et al. Findings from 2010 Global Adult Tobacco Survey: implementation of MPOWER policy in China. Biomed Environ Sci. (2010) 23:422–9. doi: 10.1016/s0895-3988(11)60002-0
50. Claussen B, Aasland OG. The Alcohol Use Disorders Identification Test (AUDIT) in a routine health examination of long-term unemployed. Addiction. (1993) 88:363–8. doi: 10.1111/j.1360-0443.1993.tb00823.x
51. Liu W, Wang T, Zhu M, Jin G. Healthy diet, polygenic risk score, and upper gastrointestinal cancer risk: a prospective study from UK Biobank. Nutrients. (2023) 15:1344. doi: 10.3390/nu15061344
52. Krass I, Taylor SJ, Smith C, Armour CL. Impact on medication use and adherence of Australian pharmacists’ diabetes care services. J Am Pharm Assoc. (2003) 45:33–40. doi: 10.1331/1544345052843093
53. Cai Q, Ye L, Horne R, Bi J, Xu Q, Ye X, et al. Patients’ adherence-related beliefs about inhaled steroids: application of the Chinese version of the Beliefs about Medicines Questionnaire-specific in patients with asthma. J Asthma. (2020) 57:319–26. doi: 10.1080/02770903.2019.1565824
54. Billinger SA, Arena R, Bernhardt J, Eng JJ, Franklin BA, Johnson CM, et al. Physical activity and exercise recommendations for stroke survivors: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. (2014) 45:2532–53. doi: 10.1161/str.0000000000000022
55. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 Adults. Circulation. (2017) 135:759–71. doi: 10.1161/circulationaha.116.025250
56. Martire LM, Lustig AP, Schulz R, Miller GE, Helgeson VS. Is it beneficial to involve a family member? A meta-analysis of psychosocial interventions for chronic illness. Health Psychol. (2004) 23:599–611. doi: 10.1037/0278-6133.23.6.599
57. Fiacco S, Mernone L, Ehlert U. Psychobiological indicators of the subjectively experienced health status - findings from the Women 40+ Healthy Aging Study. BMC Womens Health. (2020) 20:16. doi: 10.1186/s12905-020-0888-x
58. Jokar F, Asadollahi AR, Kaveh OH, Ghahramani L, Nazari M. Relationship of perceived social support with the activities of daily living in older adults living in rural communities in Iran. Salmand-Iranian J Ageing. (2020) 15:350–64. doi: 10.32598/sija.10.15.3.2773.2
59. Yani DI, Juniarti N, Lukman M. Factors related to complying with Anti-TB medications among drug-resistant tuberculosis patients in Indonesia. Patient Prefer Adherence. (2022) 16:3319–27. doi: 10.2147/ppa.S388989
60. Koch Filho HR, Koch LFA, Kusma SZ, Ignácio SA, Moysés ST, Alanis LRA, et al. Self-perception of gerontoism according to social support and family functionality. Iran J Public Health. (2019) 48:673–80.
61. Zhang L, Shu Y, Han C, Liu J. Correlation between family functioning and health beliefs in patients with stroke in Beijing, China. J Multidiscip Healthc. (2023) 16:1067–74. doi: 10.2147/jmdh.S394396
62. Zhu R, Huang H, Yu Y, Bao S, Lin N, Shu M. Post-stroke fatigue and its correlation with family functioning in patients who have experienced a first episode of stroke. Front Aging Neurosci. (2024) 16:1440163. doi: 10.3389/fnagi.2024.1440163
63. Stoll WD, Taber DJ, Palesch SJ, Hebbar L. Utility of the surgical apgar score in kidney transplantation: is it feasible to predict ICU admission, hospital readmission, length of stay, and cost in this patient population? Prog Transplant. (2016) 26:122–8. doi: 10.1177/1526924816640948
64. Yin Z, Deng Y, Li Z, Gu H, Zhou Q, Wang Y, et al. Assessment of rehabilitation following acute ischaemic stroke in China: a registry-based retrospective observational study. BMJ Open. (2024) 14:e082279. doi: 10.1136/bmjopen-2023-082279
Keywords: acute ischemic stroke, family support, functional recovery, medication adherence, cohort study
Citation: Zhong M, Zhou Y, Jia Y, Yao Y, Cheng Y, Li D, Zhang Y, Lei Y, Zhao Q, Huang J and Liao X (2025) Association between family support and 6-months functional recovery in acute ischemic stroke patients: a prospective cohort study. Front. Med. 12:1684785. doi: 10.3389/fmed.2025.1684785
Received: 13 August 2025; Revised: 18 November 2025; Accepted: 19 November 2025;
Published: 17 December 2025.
Edited by:
Thao Thi Phuong Nguyen, Vinmec Research Institute of Stem Cell and Gene Technology, VietnamReviewed by:
Julie Lynn Schwertfeger, Captain James A. Lovell Federal Health Care Center, United StatesAnand Kumar, Banaras Hindu University, India
Copyright © 2025 Zhong, Zhou, Jia, Yao, Cheng, Li, Zhang, Lei, Zhao, Huang and Liao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xiaoyang Liao, bGlhb3hpYW95YW5nQHdjaHNjdS5jbg==
Ming Zhong1